
Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 🚀
Boltz
32 posts

@boltz_bio
With AI, we help every scientist reshape biology.

Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 🚀

Over the next week, I’ll be in the US presenting some of the exciting work the Boltz team has been doing, with stops in Boston, San Diego, and New York! 🧬

It has been great to collaborate with the @NVIDIAHealth team on adding Context Parallelism to the Boltz models! Announced in the keynote at #GTC, @NVIDIA showed you can now scale up Boltz-2 to predict structures up to 30k residues (up from ~2k)! 🤯 This opens the door to a number of very cool new applications, although performance starts to drop around 3-4k residues because the current models have only been trained on smaller crops. Try it out at: github.com/jwohlwend/bolt… 🧬



Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.











At Andreessen Horowitz, we just raised over $15B. With these new funds including American Dynamism ($1.176B), Apps ($1.7B), Bio + Health ($700M), Infrastructure ($1.7B), Growth ($6.75B), and other venture strategies ($3B), we raised over 18% of all venture capital dollars allocated in the United States in 2025. Why did we raise the money and how do we plan to invest it? Read more from Ben Horowitz: a16z.news/p/we-raised-15…


Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 🚀

Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 🚀

Big news from Boltz today: we’re launching Boltz Lab, a new platform with new small-molecule + protein design agents, announcing Boltz PBC and a $28M seed round, and sharing a multi-year partnership with Pfizer. More below! 🚀